On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its SCoV-2 Detect IgG ELISA kit, which detects IgG antibodies to SARS-CoV-2 in human serum.

InBios’ COVID-19 antibody test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, the virus that causes COVID-19, which may indicate recent or prior infection.